Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal CancerRamón Salazar, Rob A.�E.�M. Tollenaar, Sjoerd C. Bruin et al.|Journal of Clinical Oncology|2010Cited by 540
International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancerEmmanouil Fokas, Claus Rödel, Ane Appelt et al.|Nature Reviews Clinical Oncology|2021Cited by 242
DUTCH COLORECTAL CANCER GROUP. PREOPERATIVE RADIOTHERAPY COMBINED WITH TOTAL MESORECTAL EXCISION FOR RESECTABLE RECTAL CANCEREllen Kapiteijn, Cornelis JH van de Velde, Corrie A.M. Marijnen et al.|Unknown|2001Cited by 229
Local and distant recurrences in rectal cancer patients are predicted by the nonspecific immune response; specific immune response has only a systemic effect - a histopathological and immunohistochemical studyIrıs D. Nagtegaal, J. Han van Krieken, Corrie A.M. Marijnen et al.|BMC Cancer|2001Cited by 142
Modern Treatment of Rectal Cancer Closes the Gap Between Common Adenocarcinoma and Mucinous CarcinomaNiek Hugen, Irıs D. Nagtegaal, Corrie A.M. Marijnen et al.|Annals of Surgical Oncology|2015Cited by 64